-
Flourishing WuXi Biologics in talks to make vaccines for scandal-hit China: report
fiercepharma
January 24, 2019
WuXi Biologics has been surfing a surge of growth in biologic drugs, but the contract manufacturer isn't just interested in novel medications. It's also eyeing an older type of therapy: vaccines, which have come under special scrutiny in China lately.
-
GSK’s chairman Sir Philip Hampton steps down
pharmaphorum
January 22, 2019
GlaxoSmithKline is searching for a new chairman after Sir Philip Hampton announced he is to step down in the wake of the company’s split into two businesses.
-
Further scandal for China’s pharmaceutical industry
europeanpharmaceuticalreview
January 15, 2019
Chinese police say they have opened an investigation into reports that at least 145 children received an expired polio vaccine…
-
Sanofi plots 670 layoffs in France as local tensions brew
fiercepharma
December 10, 2018
Sanofi may be on the up-and-up thanks to its vaccines unit and new anti-inflammatory star Dupixent, but the company still intends to shed more than 600 jobs in its home country over the next couple of years.
-
NIHR streams ￡5m into global infectious diseases research
pharmatimes
November 19, 2018
The National Institute for Health Research is streaming ￡5 million of global health funding into research looking at how infectious diseases spread
-
DNAtrix, Valo Therapeutics Announce Partnership
americanpharmaceuticalreview
November 14, 2018
DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology.
-
DNAtrix, Valo Therapeutics Announce Partnership
americanpharmaceuticalreview
November 14, 2018
DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology.
-
Is Moderna prepping for biotech's biggest-ever IPO?
fiercebiotech
September 14, 2018
Modera Therapeutics is one of a select group of biotech "unicorns."
-
ImmusanT to develop Type 1 diabetes vaccine with JDRF backing
fiercebiotech
September 12, 2018
JDRF plans to do more than just support ImmusanT with a VC investment, and will engage in a collaboration on the project.
-
A Review of the Vaccines Marketed in China: 63 Varieties of Vaccines from 45 Enterprises
1℃
August 10, 2018
The vaccine incident of Changsheng Bio-technology has continued to simmer recently. Vaccine fabrication is something absolutely intolerable.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
